Notice2025-00977
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 16, 2025
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 10 (Thursday, January 16, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 10 (Thursday, January 16, 2025)]
[Notices]
[Pages 4752-4753]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-00977]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and contract proposals and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications and
contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; PLCO U01 SEP Review Meeting.
Date: February 12, 2025.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W102, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Shakeel Ahmad, Ph.D., Branch Chief, Research
Technology and Contract Review, Branch Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W102, Rockville, Maryland 20850, 240-276-6442,
<a href="/cdn-cgi/l/email-protection#c6a7aeaba7a2b586aba7afaae8a8afaee8a1a9b0"><span class="__cf_email__" data-cfemail="bbdad3d6dadfc8fbd6dad2d795d5d2d395dcd4cd">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-7: SBIR Contract Review Meeting (Review of SBIR Topics
431 and 439).
Date: February 20, 2025.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Address: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Susan Lynn Spence, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850, 240-620-0819,
<a href="/cdn-cgi/l/email-protection#2d5e585e4c43035e5d48434e486d434445034a425b"><span class="__cf_email__" data-cfemail="3a494f495b5414494a5f54595f7a545352145d554c">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-9: NCI Clinical and Translational Cancer Research.
Date: February 27, 2025.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W542, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Biman Chandra Paria, Ph.D., Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W542, Rockville, Maryland 20850, 240-858-3814,
<a href="/cdn-cgi/l/email-protection#ff8f9e8d969e9dbf929e9693d1919697d1989089"><span class="__cf_email__" data-cfemail="6f1f0e1d060e0d2f020e06034101060741080019">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Research Specialist Award (R50) Clinician Scientist.
Date: March 11-12, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W526, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Viktoriya Sidorenko, Ph.D., Scientific Review
Officer, Program and Review Extramural Staff Training Office,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W526, Rockville, Maryland 20850,
240-276-5073, <a href="/cdn-cgi/l/email-protection#84f2edeff0ebf6edfde5aaf7ede0ebf6e1eaefebc4eaedecaae3ebf2"><span class="__cf_email__" data-cfemail="fa8c93918e958893839bd489939e95889f949195ba949392d49d958c">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI SEP: The Confluence of Cancer Stigma and HIV Stigma in
HIV-positive Individuals (R01 and R21).
Date: March 20, 2025.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 4753]]
Address: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W244, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Ryan Gleason, Ph.D., Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W244, Rockville, Maryland 20850, 240-276-7329,
<a href="/cdn-cgi/l/email-protection#d7a5aeb6b9f9b0bbb2b6a4b8b997b9bebff9b0b8a1"><span class="__cf_email__" data-cfemail="8cfef5ede2a2ebe0e9edffe3e2cce2e5e4a2ebe3fa">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: January 10, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2025-00977 Filed 1-15-25; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 16, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.